Drug prices up before reform

healthcare reformWhile drug makers promise to back healthcare reform by cutting drug costs after legislation passes, the industry has been raising  drug prices at a 9-percent clip.  Law Professor Kevin Outterson, an authority on pharmaceutical law and marketing, says this means big pharma will make more money from health reform.

“This is apparently the price for PhRMA’s support of broader health reform.”

Contact Kevin Outterson, 617-353-3103, mko@bu.edu

Post a Comment

Your email address is never shared. Required fields are marked *